DOUBLE-BLIND CROSS-OVER STUDY OF ORUDIS AND PLACEBO IN FIFTY PATIENTS WITH RHEUMATOID ARTHRITIS

Abstract
In a double-blind cross-over study of Orudis and placebo in 50 patients with active rheumatoid arthritis, symptomatic relief produced by Orudis was found to be significantly greater (p <0.01) than by placebo. Toxic effects were few and trivial.